JP5236286B2 - 肝線維症に関連する遺伝的多型、その検出方法および使用 - Google Patents

肝線維症に関連する遺伝的多型、その検出方法および使用 Download PDF

Info

Publication number
JP5236286B2
JP5236286B2 JP2007511675A JP2007511675A JP5236286B2 JP 5236286 B2 JP5236286 B2 JP 5236286B2 JP 2007511675 A JP2007511675 A JP 2007511675A JP 2007511675 A JP2007511675 A JP 2007511675A JP 5236286 B2 JP5236286 B2 JP 5236286B2
Authority
JP
Japan
Prior art keywords
snp
nucleic acid
snps
kit
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2007511675A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009523005A5 (enExample
JP2009523005A (ja
Inventor
ミシェル カーギル，
ホンジン ファン，
Original Assignee
セレラ コーポレーション
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by セレラ コーポレーション filed Critical セレラ コーポレーション
Publication of JP2009523005A publication Critical patent/JP2009523005A/ja
Publication of JP2009523005A5 publication Critical patent/JP2009523005A5/ja
Application granted granted Critical
Publication of JP5236286B2 publication Critical patent/JP5236286B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
JP2007511675A 2004-05-07 2005-05-09 肝線維症に関連する遺伝的多型、その検出方法および使用 Expired - Lifetime JP5236286B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US56884604P 2004-05-07 2004-05-07
US60/568,846 2004-05-07
US58260904P 2004-06-25 2004-06-25
US60/582,609 2004-06-25
US59955404P 2004-08-09 2004-08-09
US60/599,554 2004-08-09
PCT/US2005/016051 WO2005111241A2 (en) 2004-05-07 2005-05-09 Genetic polymorphisms associated with liver fibrosis methods of detection and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011023321A Division JP2011142914A (ja) 2004-05-07 2011-02-04 肝線維症に関連する遺伝的多型、その検出方法および使用

Publications (3)

Publication Number Publication Date
JP2009523005A JP2009523005A (ja) 2009-06-18
JP2009523005A5 JP2009523005A5 (enExample) 2009-07-30
JP5236286B2 true JP5236286B2 (ja) 2013-07-17

Family

ID=35394750

Family Applications (8)

Application Number Title Priority Date Filing Date
JP2007511675A Expired - Lifetime JP5236286B2 (ja) 2004-05-07 2005-05-09 肝線維症に関連する遺伝的多型、その検出方法および使用
JP2011023321A Withdrawn JP2011142914A (ja) 2004-05-07 2011-02-04 肝線維症に関連する遺伝的多型、その検出方法および使用
JP2013143224A Withdrawn JP2013233150A (ja) 2004-05-07 2013-07-09 肝線維症に関連する遺伝的多型、その検出方法および使用
JP2013143223A Expired - Lifetime JP5733844B2 (ja) 2004-05-07 2013-07-09 肝線維症に関連する遺伝的多型、その検出方法および使用
JP2015182498A Expired - Lifetime JP6124968B2 (ja) 2004-05-07 2015-09-16 肝線維症に関連する遺伝的多型、その検出方法および使用
JP2015182499A Withdrawn JP2016027815A (ja) 2004-05-07 2015-09-16 肝線維症に関連する遺伝的多型、その検出方法および使用
JP2017176520A Withdrawn JP2018023392A (ja) 2004-05-07 2017-09-14 肝線維症に関連する遺伝的多型、その検出方法および使用
JP2017176519A Expired - Fee Related JP6448149B2 (ja) 2004-05-07 2017-09-14 肝線維症に関連する遺伝的多型、その検出方法および使用

Family Applications After (7)

Application Number Title Priority Date Filing Date
JP2011023321A Withdrawn JP2011142914A (ja) 2004-05-07 2011-02-04 肝線維症に関連する遺伝的多型、その検出方法および使用
JP2013143224A Withdrawn JP2013233150A (ja) 2004-05-07 2013-07-09 肝線維症に関連する遺伝的多型、その検出方法および使用
JP2013143223A Expired - Lifetime JP5733844B2 (ja) 2004-05-07 2013-07-09 肝線維症に関連する遺伝的多型、その検出方法および使用
JP2015182498A Expired - Lifetime JP6124968B2 (ja) 2004-05-07 2015-09-16 肝線維症に関連する遺伝的多型、その検出方法および使用
JP2015182499A Withdrawn JP2016027815A (ja) 2004-05-07 2015-09-16 肝線維症に関連する遺伝的多型、その検出方法および使用
JP2017176520A Withdrawn JP2018023392A (ja) 2004-05-07 2017-09-14 肝線維症に関連する遺伝的多型、その検出方法および使用
JP2017176519A Expired - Fee Related JP6448149B2 (ja) 2004-05-07 2017-09-14 肝線維症に関連する遺伝的多型、その検出方法および使用

Country Status (5)

Country Link
US (7) US7820380B2 (enExample)
EP (5) EP2412826B1 (enExample)
JP (8) JP5236286B2 (enExample)
CA (2) CA2566256C (enExample)
WO (1) WO2005111241A2 (enExample)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7666584B2 (en) * 2005-09-01 2010-02-23 Philadelphia Health & Education Coporation Identification of a pin specific gene and protein (PIN-1) useful as a diagnostic treatment for prostate cancer
US7727725B2 (en) 2006-04-27 2010-06-01 Celera Corporation Genetic polymorphisms associated with liver fibrosis, methods of detection and uses thereof
EP2099467B1 (en) * 2006-10-03 2017-05-10 University Of Medicine And Dentistry Of New Jersey Atap peptides, nucleic acids encoding the same and associated methods of use
WO2008132763A2 (en) * 2007-04-30 2008-11-06 Decode Genetics Ehf Genetic variants useful for risk assessment of coronary artery disease and myocardial infarction
US8039212B2 (en) * 2007-11-05 2011-10-18 Celera Corporation Genetic polymorphisms associated with liver fibrosis, methods of detection and uses thereof
WO2009147246A1 (en) * 2008-06-06 2009-12-10 Medizinische Universität Graz Compounds reducing or inhibiting the expression of pkd1 for diagnosis and therapy of brain tumors
EP2389439A4 (en) * 2009-01-23 2013-02-13 Agency Science Tech & Res EINBASEN POLYMORPHISM IN AN INTRONIC P53 BINDING MOTIF OF THE PRKAG2 GENE
US10307167B2 (en) 2012-12-14 2019-06-04 Corquest Medical, Inc. Assembly and method for left atrial appendage occlusion
US10813630B2 (en) 2011-08-09 2020-10-27 Corquest Medical, Inc. Closure system for atrial wall
US10314594B2 (en) 2012-12-14 2019-06-11 Corquest Medical, Inc. Assembly and method for left atrial appendage occlusion
ME03009B (me) 2011-09-16 2018-10-20 Gilead Pharmasset Llc Metode za lecenje hcv-a
US8889159B2 (en) 2011-11-29 2014-11-18 Gilead Pharmasset Llc Compositions and methods for treating hepatitis C virus
ES2423154B1 (es) * 2012-03-12 2014-07-15 Universidad Autónoma de Madrid Método in vitro de pronóstico de cirrosis hepática
ES2422874B1 (es) * 2012-03-12 2014-07-15 Universidad Autnoma De Madrid Método in vitro de pronóstico de fibrosis hepática grave
CN103570553B (zh) 2012-08-01 2016-08-10 中国科学院兰州化学物理研究所 一种通过催化烷基化制备n-取代胺类化合物的方法
US20140142689A1 (en) 2012-11-21 2014-05-22 Didier De Canniere Device and method of treating heart valve malfunction
UA118256C2 (uk) 2013-01-31 2018-12-26 Гіліад Фармассет Елелсі Комбінований склад двох противірусних сполук
WO2015014763A2 (en) * 2013-08-02 2015-02-05 Echosens Non-invasive system for calculating a human or animal, reliable, standardized and complete score
US9566443B2 (en) 2013-11-26 2017-02-14 Corquest Medical, Inc. System for treating heart valve malfunction including mitral regurgitation
US10842626B2 (en) 2014-12-09 2020-11-24 Didier De Canniere Intracardiac device to correct mitral regurgitation
CN110446785B (zh) * 2017-01-23 2024-04-26 瑞泽恩制药公司 Hsd17b13变体及其应用
KR20190139869A (ko) 2017-04-11 2019-12-18 리제너론 파마슈티칼스 인코포레이티드 하이드록시스테로이드 (17-베타) 탈수소효소(hsd17b) 패밀리의 구성원의 조절인자의 활성도를 스크리닝하기 위한 검정
US10961583B2 (en) 2017-10-11 2021-03-30 Regeneron Phramaceuticals, Inc. Inhibition of HSD17B13 in the treatment of liver disease in patients expressing the PNPLA3 I148M variation
CA3091146A1 (en) 2018-03-21 2019-09-26 Regeneron Pharmaceuticals, Inc. 17.beta.-hydroxysteroid dehydrogenase type 13 (hsd17b13) irna compositions and methods of use thereof
US11216742B2 (en) 2019-03-04 2022-01-04 Iocurrents, Inc. Data compression and communication using machine learning
WO2021051009A1 (en) * 2019-09-11 2021-03-18 City Of Hope Methods and compositions to direct breakdown of insulin mrna in benign fashion
EP4055174A4 (en) * 2019-11-08 2024-01-03 The Board Of Regents Of The University Of Texas System Transgene cassettes, aav vectors and aav viral vectors for the expression of human codon-optimized slc6a1
WO2021222623A1 (en) * 2020-04-29 2021-11-04 Washington University Compositions and methods for inhibiting viral recognition sites
KR102455051B1 (ko) * 2020-05-08 2022-10-17 가톨릭대학교 산학협력단 혈청내 Daxx 단백질의 측정을 통한 만성 간질환의 진단
GB202008269D0 (en) * 2020-06-02 2020-07-15 Oxford Biodynamics Ltd Detecting a chromosome marker
US12097498B2 (en) 2020-12-31 2024-09-24 3M Innovative Properties Company Nanopatterned films with patterned surface chemistry
IL308883A (en) * 2021-05-28 2024-01-01 Arrowhead Pharmaceuticals Inc RNAi AGENTS FOR INHIBITING EXPRESSION OF MUCIN 5AC (MUC5AC), COMPOSITIONS THEREOF, AND METHODS OF USE
IL311468A (en) * 2021-09-22 2024-05-01 Imagine Pharma Llc Compositions and methods for the proliferation of insulin- and glucagon-secreting cells from type 1 diabetic pancreatic tissue and their therapeutic uses
CA3238030A1 (en) * 2021-11-12 2023-05-19 Research Institute At Nationwide Children's Hospital Materials and methods for slc6a1 gene therapy

Family Cites Families (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4107288A (en) 1974-09-18 1978-08-15 Pharmaceutical Society Of Victoria Injectable compositions, nanoparticles useful therein, and process of manufacturing same
US4458066A (en) 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides
US4873191A (en) 1981-06-12 1989-10-10 Ohio University Genetic transformation of zygotes
US4870009A (en) 1982-11-22 1989-09-26 The Salk Institute For Biological Studies Method of obtaining gene product through the generation of transgenic animals
FR2540122B1 (fr) 1983-01-27 1985-11-29 Centre Nat Rech Scient Nouveaux composes comportant une sequence d'oligonucleotide liee a un agent d'intercalation, leur procede de synthese et leur application
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4736866A (en) 1984-06-22 1988-04-12 President And Fellows Of Harvard College Transgenic non-human mammals
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
NO870613L (no) 1986-03-05 1987-09-07 Molecular Diagnostics Inc Deteksjon av mikroorganismer i en prŸve inneholdende nukleinsyre.
US5004565A (en) 1986-07-17 1991-04-02 The Board Of Governors Of Wayne State University Method and compositions providing enhanced chemiluminescence from 1,2-dioxetanes
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5637677A (en) 1987-07-16 1997-06-10 The Trustees Of The University Of Pennsylvania Biologically active compounds and methods of constructing and using the same
US5080891A (en) 1987-08-03 1992-01-14 Ddi Pharmaceuticals, Inc. Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols
US5856522A (en) 1995-05-04 1999-01-05 Tropix, Inc. Method of using synthesis of 1,2-dioxetanes and kits therefore
US4988617A (en) 1988-03-25 1991-01-29 California Institute Of Technology Method of detecting a nucleotide change in nucleic acids
DE68928853T2 (de) 1988-05-20 1999-08-05 Cetus Corp., Emeryville, Calif. Befestigung von sequenzspezifischen proben
US4988167A (en) 1988-08-10 1991-01-29 Fergason James L Light blocking and vision restoration apparatus with glint control
US5118801A (en) 1988-09-30 1992-06-02 The Public Health Research Institute Nucleic acid process containing improved molecular switch
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
CA2020958C (en) 1989-07-11 2005-01-11 Daniel L. Kacian Nucleic acid sequence amplification methods
US5494810A (en) 1990-05-03 1996-02-27 Cornell Research Foundation, Inc. Thermostable ligase-mediated DNA amplifications system for the detection of genetic disease
US5210015A (en) 1990-08-06 1993-05-11 Hoffman-La Roche Inc. Homogeneous assay system using the nuclease activity of a nucleic acid polymerase
US5994073A (en) 1990-08-30 1999-11-30 Tropix, Inc. Enhancement of chemiluminescent assays
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
US5714331A (en) 1991-05-24 1998-02-03 Buchardt, Deceased; Ole Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility
US5539082A (en) 1993-04-26 1996-07-23 Nielsen; Peter E. Peptide nucleic acids
ES2136092T3 (es) 1991-09-23 1999-11-16 Medical Res Council Procedimientos para la produccion de anticuerpos humanizados.
US5270184A (en) 1991-11-19 1993-12-14 Becton, Dickinson And Company Nucleic acid target generation
EP0655090B1 (en) 1992-04-27 2000-12-27 The Trustees Of Dartmouth College Detection of gene sequences in biological fluids
DE69333969T2 (de) 1992-10-30 2006-09-14 The General Hospital Corp., Boston Wechselwirkendes Fallensystem zur Isolierung von Proteinen
EP1262564A3 (en) 1993-01-07 2004-03-31 Sequenom, Inc. Dna sequencing by mass spectrometry
US5422252A (en) 1993-06-04 1995-06-06 Becton, Dickinson And Company Simultaneous amplification of multiple targets
US5837832A (en) 1993-06-25 1998-11-17 Affymetrix, Inc. Arrays of nucleic acid probes on biological chips
WO1995011995A1 (en) 1993-10-26 1995-05-04 Affymax Technologies N.V. Arrays of nucleic acid probes on biological chips
US6027923A (en) 1993-07-23 2000-02-22 Bio-Rad Laboratories, Inc. Linked linear amplification of nucleic acids
US5527675A (en) 1993-08-20 1996-06-18 Millipore Corporation Method for degradation and sequencing of polymers which sequentially eliminate terminal residues
US5498531A (en) 1993-09-10 1996-03-12 President And Fellows Of Harvard College Intron-mediated recombinant techniques and reagents
DE4331012A1 (de) 1993-09-13 1995-03-16 Bayer Ag Nukleinsäuren-bindende Oligomere mit N-Verzweigung für Therapie und Diagnostik
US5538848A (en) 1994-11-16 1996-07-23 Applied Biosystems Division, Perkin-Elmer Corp. Method for detecting nucleic acid amplification using self-quenching fluorescence probe
US6015880A (en) 1994-03-16 2000-01-18 California Institute Of Technology Method and substrate for performing multiple sequential reactions on a matrix
US5807522A (en) 1994-06-17 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for fabricating microarrays of biological samples
US5773628A (en) 1994-11-14 1998-06-30 Tropix, Inc. 1,2-dioxetane compounds with haloalkoxy groups, methods preparation and use
US5591591A (en) 1995-02-09 1997-01-07 Tropix, Inc. Dioxetane compounds for the chemiluminescent detection of proteases, methods of use and kits therefore
US5589136A (en) 1995-06-20 1996-12-31 Regents Of The University Of California Silicon-based sleeve devices for chemical reactions
GB9517780D0 (en) 1995-08-31 1995-11-01 Roslin Inst Edinburgh Biological manipulation
GB9517779D0 (en) 1995-08-31 1995-11-01 Roslin Inst Edinburgh Biological manipulation
US5801115A (en) 1995-09-05 1998-09-01 Kataleuna Gmbh Catalyst composition and methods for using and preparing same
US5679803A (en) 1995-10-25 1997-10-21 Tropix, Inc. 1,2 chemiluminescent dioxetanes of improved performance
EP2573101B1 (en) 1996-02-09 2016-04-20 Cornell Research Foundation, Inc. Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
US5885470A (en) 1997-04-14 1999-03-23 Caliper Technologies Corporation Controlled fluid transport in microfabricated polymeric substrates
JP2000508912A (ja) 1996-04-19 2000-07-18 スペクトラ バイオメディカル，インコーポレイテッド 多型形態と複数の表現型との相関付け
WO1997045559A1 (en) 1996-05-29 1997-12-04 Cornell Research Foundation, Inc. Detection of nucleic acid sequence differences using coupled ligase detection and polymerase chain reactions
US6117635A (en) 1996-07-16 2000-09-12 Intergen Company Nucleic acid amplification oligonucleotides with molecular energy transfer labels and methods based thereon
US5866336A (en) 1996-07-16 1999-02-02 Oncor, Inc. Nucleic acid amplification oligonucleotides with molecular energy transfer labels and methods based thereon
US5800999A (en) 1996-12-16 1998-09-01 Tropix, Inc. Dioxetane-precursor-labeled probes and detection assays employing the same
EP0988529B1 (en) 1997-04-25 2013-06-12 Caliper Life Sciences, Inc. Microfluidic devices incorporating improved channel geometries
US6119096A (en) 1997-07-31 2000-09-12 Eyeticket Corporation System and method for aircraft passenger check-in and boarding using iris recognition
US6506594B1 (en) 1999-03-19 2003-01-14 Cornell Res Foundation Inc Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
US20030092019A1 (en) * 2001-01-09 2003-05-15 Millennium Pharmaceuticals, Inc. Methods and compositions for diagnosing and treating neuropsychiatric disorders such as schizophrenia
WO2002072889A2 (en) 2001-01-12 2002-09-19 Applera Corporation Methods and compositions for microarray control
US20030119010A1 (en) * 2001-03-01 2003-06-26 University Of Queensland Polynucleotides and polypeptides linked to a disease or condition
JP2004537289A (ja) * 2001-05-11 2004-12-16 ゲノム　セラピューティックス　コーポレーション 骨量および脂質レベルを調整するｈｂｍ変異型
GB0209812D0 (en) * 2002-04-30 2002-06-05 Renovo Ltd Genetic testing

Also Published As

Publication number Publication date
JP6448149B2 (ja) 2019-01-09
US20160032388A1 (en) 2016-02-04
EP2423326A2 (en) 2012-02-29
US7820380B2 (en) 2010-10-26
EP2412827A2 (en) 2012-02-01
EP2412826A3 (en) 2012-05-02
EP2423326B1 (en) 2014-01-08
CA2852855C (en) 2016-07-05
US20210025000A1 (en) 2021-01-28
JP2016005480A (ja) 2016-01-14
US8071302B2 (en) 2011-12-06
JP2011142914A (ja) 2011-07-28
WO2005111241A2 (en) 2005-11-24
JP5733844B2 (ja) 2015-06-10
JP6124968B2 (ja) 2017-05-10
EP1745154A2 (en) 2007-01-24
WO2005111241A8 (en) 2006-12-28
CA2852855A1 (en) 2005-11-24
JP2016027815A (ja) 2016-02-25
EP2423326A3 (en) 2012-06-13
JP2018023392A (ja) 2018-02-15
US20110129831A1 (en) 2011-06-02
CA2566256C (en) 2015-07-07
WO2005111241A3 (en) 2006-06-01
EP2423327B1 (en) 2014-01-08
JP2009523005A (ja) 2009-06-18
US20060024700A1 (en) 2006-02-02
EP2412827A3 (en) 2012-05-16
CA2566256A1 (en) 2005-11-24
JP2018023391A (ja) 2018-02-15
US20140072957A1 (en) 2014-03-13
EP2412826A2 (en) 2012-02-01
EP2412827B1 (en) 2014-01-22
US10718023B2 (en) 2020-07-21
EP2412826B1 (en) 2014-01-08
JP2013233150A (ja) 2013-11-21
JP2014027931A (ja) 2014-02-13
EP2423327A2 (en) 2012-02-29
EP2423327A3 (en) 2012-05-23
EP1745154B1 (en) 2012-08-01
US20190127796A1 (en) 2019-05-02
US20120276528A1 (en) 2012-11-01

Similar Documents

Publication Publication Date Title
JP5236286B2 (ja) 肝線維症に関連する遺伝的多型、その検出方法および使用
JP6529193B2 (ja) 心筋梗塞に関連する遺伝的多型、その検出方法および使用
JP6537150B2 (ja) 心臓血管障害および薬物応答に関連した遺伝子多型、それらの検出方法および用途
US11408034B2 (en) Genetic polymorphisms associated with cardiovascular diseases, methods of detection and uses thereof
DK2121979T3 (en) Genetic markers for risk management of cardiac arrhythmia
JP2009521205A (ja) 発作に関連する遺伝的多型、その検出方法および使用
EP2639317B1 (en) Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof
JP2013542735A (ja) 静脈血栓症と関連する遺伝子多型およびスタチン応答、その検出方法ならびにその用途
JP2009520460A (ja) 心筋梗塞に関連する遺伝的多型、その検出方法および使用
EP1476067A2 (en) Novel compositions and methods for cancer
JP2006521812A (ja) 慢性関節リウマチに関連する遺伝的多型、その検出方法および使用
JP2009523006A (ja) 脈管疾患に関連する遺伝的多型、その検出方法および使用
US20090258003A1 (en) Genetic polymorphisms associated with venous thrombosis, methods of detection and uses thereof
JP2009523405A (ja) 冠動脈心疾患に関連する遺伝的多型、その検出方法および使用
CA2826522C (en) Genetic polymorphism in pnlpa3 associated with liver fibrosis methods of detection and uses thereof

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20101108

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110204

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20110204

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20111108

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120130

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20120904

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20121227

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20130124

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20130326

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20130327

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

Ref document number: 5236286

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20160405

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250